172 related articles for article (PubMed ID: 2559040)
1. Effects of oral base therapy on serum ionized calcium, phosphorus and parathyroid hormone in chronic hemodialysis patients.
Caruana RJ; Weinstein RS; Campbell HT; Chaudhary BA; Smith KL; Kurunsaari KM
Int J Artif Organs; 1989 Dec; 12(12):778-81. PubMed ID: 2559040
[TBL] [Abstract][Full Text] [Related]
2. Rapid correction of metabolic acidosis in chronic renal failure: effect on parathyroid hormone activity.
Lu KC; Shieh SD; Li BL; Chu P; Jan SY; Lin YF
Nephron; 1994; 67(4):419-24. PubMed ID: 7969674
[TBL] [Abstract][Full Text] [Related]
3. Direct effect of the correction of acidosis on plasma parathyroid hormone concentrations, calcium and phosphate in hemodialysis patients: a prospective study.
Movilli E; Zani R; Carli O; Sangalli L; Pola A; Camerini C; Scolari F; Cancarini GC; Maiorca R
Nephron; 2001 Mar; 87(3):257-62. PubMed ID: 11287761
[TBL] [Abstract][Full Text] [Related]
4. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
5. Influence of metabolic acidosis on serum 1,25(OH)2D3 levels in chronic renal failure.
Lu KC; Lin SH; Yu FC; Chyr SH; Shieh SD
Miner Electrolyte Metab; 1995; 21(6):398-402. PubMed ID: 8592483
[TBL] [Abstract][Full Text] [Related]
6. The role of oral sodium bicarbonate supplementation in maintaining acid-base balance and its influence on the cardiovascular system in chronic hemodialysis patients - results of a prospective study.
Voiculeț C; Zară O; Bogeanu C; Văcăroiu I; Aron G
J Med Life; 2016; 9(4):449-454. PubMed ID: 27928454
[No Abstract] [Full Text] [Related]
7. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients.
Brady JP; Hasbargen JA
Am J Kidney Dis; 1998 Jan; 31(1):35-40. PubMed ID: 9428449
[TBL] [Abstract][Full Text] [Related]
8. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
[TBL] [Abstract][Full Text] [Related]
9. Radioimmunoassay of carboxyl and amino terminal fragments of parathyroid hormone for the evaluation of secondary hyperparathyroidism in chronic renal failure.
Zanella MT; Silva MC; Peres RB; Ferreira SR; Draibe SA; Vieira JG
Braz J Med Biol Res; 1990; 23(3-4):235-43. PubMed ID: 2094538
[TBL] [Abstract][Full Text] [Related]
10. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
11. Effect Modifying Role of Serum Calcium on Mortality-Predictability of PTH and Alkaline Phosphatase in Hemodialysis Patients: An Investigation Using Data from the Taiwan Renal Registry Data System from 2005 to 2012.
Lin YC; Lin YC; Hsu CY; Kao CC; Chang FC; Chen TW; Chen HH; Hsu CC; Wu MS;
PLoS One; 2015; 10(6):e0129737. PubMed ID: 26107510
[TBL] [Abstract][Full Text] [Related]
12. The differences in acid-base status and the calcium parathyroid axis between peritoneal dialysis and hemodialysis.
Morishita M; Matsuo N; Maruyama Y; Nakao M; Yamamoto I; Tanno Y; Ohkido I; Ikeda M; Yokoyama K; Yokoo T
Clin Nephrol; 2016 Aug; 86(2):55-61. PubMed ID: 27345183
[TBL] [Abstract][Full Text] [Related]
13. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. The RenaGel Study Group.
Slatopolsky EA; Burke SK; Dillon MA
Kidney Int; 1999 Jan; 55(1):299-307. PubMed ID: 9893140
[TBL] [Abstract][Full Text] [Related]
14. Intravenous alfacalcidol once versus twice or thrice weekly in hemodialysis patients.
Alghareeb A; Sabry A; Bawadekji H; Alsaran K
Ther Apher Dial; 2013 Feb; 17(1):30-4. PubMed ID: 23379490
[TBL] [Abstract][Full Text] [Related]
15. Changes of serum calcium, phosphorus, and parathyroid hormone concentrations and ocular findings among patients undergoing hemodialysis.
Pakdel F; Samimagham H; Shafaroodi A; Sheikhvatan M
Saudi J Kidney Dis Transpl; 2011 Nov; 22(6):1142-8. PubMed ID: 22089771
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients.
Guh JY; Chen HC; Chuang HY; Huang SC; Chien LC; Lai YH
Am J Kidney Dis; 2002 Jun; 39(6):1245-54. PubMed ID: 12046038
[TBL] [Abstract][Full Text] [Related]
17. Effects of reduced dialysate calcium on calcium-phosphorus product and bone metabolism in hemodialysis patients.
Fiedler R; Deuber HJ; Langer T; Osten B; Mohan S; Jehle PM
Nephron Clin Pract; 2004; 96(1):c3-9. PubMed ID: 14752247
[TBL] [Abstract][Full Text] [Related]
18. Nicotinamide suppresses hyperphosphatemia in hemodialysis patients.
Takahashi Y; Tanaka A; Nakamura T; Fukuwatari T; Shibata K; Shimada N; Ebihara I; Koide H
Kidney Int; 2004 Mar; 65(3):1099-104. PubMed ID: 14871431
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
[TBL] [Abstract][Full Text] [Related]
20. Influence of rapid correction of metabolic acidosis on serum osteocalcin level in chronic renal failure.
Lin YF; Shieh SD; Diang LK; Lin SH; Chyr SH; Li BL; Lu KC
ASAIO J; 1994; 40(3):M440-4. PubMed ID: 8555554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
